The value of treatment for infertility: A systematic literature review of willingness-to-pay thresholds and approaches for determining the cost effectiveness of fertility therapies

other OA: hybrid CC-BY-4.0
AI-generated summary by gemini-2.5-flash-lite, 2026-06-14

This systematic review found no standard willingness-to-pay thresholds or outcomes for infertility treatments, highlighting methodological variations and the need for health economists to develop consensus for assessing the cost-effectiveness of ART.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Willingness to pay (WTP) for an infertility treatment is the maximum amount of money a patient is willing to pay per treatment, or to achieve a live birth or pregnancy. Such thresholds are important to determine the cost effectiveness of a treatment. A systematic review was conducted to identify and explore the studies that attempt to ascertain WTP for infertility and compare them with the cost-effectiveness studies that claimed to use WTP thresholds. For comparison, all the costs were converted and inflated to 2021 euros. The results demonstrated that there were no standard outcomes or WTP thresholds for an outcome/treatment, and the methodologies used vary. Cost-effectiveness studies either used the incremental cost-effectiveness ratio to imply a WTP threshold, or used thresholds that were previously accepted for a quality-adjusted life year outcome converted, inappropriately, to an infertility outcome. There is a need for further research by health economists to develop a consensus for the meaningful assessment of WTP for ART.

My notes (saved in your browser only)

Condition tags

infertility

MeSH descriptors

Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis Cost-Effectiveness Analysis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00
pubmed
last seen: 2026-09-17T06:15:28.229987+00:00
unpaywall
last seen: 2026-05-15T02:00:00.661756+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine